PYURE demonstrated in an independent US certified scientific lab that its FDA-registered product significantly destroys the COVID-19 virus in the air and on surfaces
3 February 2021: CAE and PYURE have signed a contract to assemble air sanitizers using PYURE’s technology and plans to produce 55,000 units during the first year. The technique is found to have a significant impact in destroying the COVID-19 virus in air and on surfaces. CAE further work plans to retrofit its facilities and simulators with this technology.
Marc Parent, President and CEO of CAE said, “The contract with PYURE will allow us to maintain manufacturing jobs in Montreal while continuing to play a role in the fight against the pandemic. We obtained this contract mainly because of the expertise we have gained developing the CAE Air1 ventilators as well as the ISO 13485:2016 certification for medical device design, manufacturing and distribution obtained last month.”
PYURE Chief Executive Officer Jean-François Huc said, “Unlike conventional air purifiers, our technology does not limit purification to the air that is pulled through the unit. PYURE’s innovative, patented technology replicates the way sunlight sanitizes the outdoor environment by safely generating and diffusing hydroxyls and organic oxidants indoors.
All PYURE air sanitization products and solutions are powered by the same hydroxyl and organic oxidant generating technology. PYURE’s MDU/Rx product is registered with the FDA as a class II medical device. A US Study shows that on surfaces the PYURE MDU/Rx sanitizer reduced the virus by 99% in one hour and it was no longer detected on surfaces after three hours.
